Logo image of CLF

CLEVELAND-CLIFFS INC (CLF) Stock Fundamental Analysis

NYSE:CLF - New York Stock Exchange, Inc. - US1858991011 - Common Stock - Currency: USD

10.155  -0.37 (-3.47%)

Fundamental Rating

2

Overall CLF gets a fundamental rating of 2 out of 10. We evaluated CLF against 157 industry peers in the Metals & Mining industry. CLF may be in some trouble as it scores bad on both profitability and health. CLF is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CLF had negative earnings in the past year.
In the past year CLF has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CLF reported negative net income in multiple years.
CLF had a positive operating cash flow in 4 of the past 5 years.
CLF Yearly Net Income VS EBIT VS OCF VS FCFCLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

CLF has a Return On Assets of -8.14%. This is in the lower half of the industry: CLF underperforms 68.15% of its industry peers.
With a Return On Equity value of -27.59%, CLF is not doing good in the industry: 76.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.14%
ROE -27.59%
ROIC N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
CLF Yearly ROA, ROE, ROICCLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CLF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLF Yearly Profit, Operating, Gross MarginsCLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

CLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLF has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CLF has been increased compared to 5 years ago.
Compared to 1 year ago, CLF has a worse debt to assets ratio.
CLF Yearly Shares OutstandingCLF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CLF Yearly Total Debt VS Total AssetsCLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CLF has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
CLF has a Debt to Equity ratio of 1.28. This is amonst the worse of the industry: CLF underperforms 87.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.69%
CLF Yearly LT Debt VS Equity VS FCFCLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

CLF has a Current Ratio of 2.04. This indicates that CLF is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CLF (2.04) is comparable to the rest of the industry.
A Quick Ratio of 0.61 indicates that CLF may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.61, CLF is doing worse than 85.99% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 0.61
CLF Yearly Current Assets VS Current LiabilitesCLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

CLF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -624.62%.
The Revenue for CLF has decreased by -12.14% in the past year. This is quite bad
The Revenue has been growing by 57.33% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-624.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23195.24%
Revenue 1Y (TTM)-12.14%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-3.1%

3.2 Future

Based on estimates for the next years, CLF will show a very strong growth in Earnings Per Share. The EPS will grow by 27.40% on average per year.
CLF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.94% yearly.
EPS Next Y-67.64%
EPS Next 2Y41.2%
EPS Next 3Y27.4%
EPS Next 5YN/A
Revenue Next Year1.01%
Revenue Next 2Y3.19%
Revenue Next 3Y3.45%
Revenue Next 5Y1.94%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLF Yearly Revenue VS EstimatesCLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CLF Yearly EPS VS EstimatesCLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLF. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLF. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLF Price Earnings VS Forward Price EarningsCLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLF Per share dataCLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as CLF's earnings are expected to grow with 27.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.2%
EPS Next 3Y27.4%

More info and screens

0

5. Dividend

5.1 Amount

CLF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEVELAND-CLIFFS INC

NYSE:CLF (8/1/2025, 11:09:10 AM)

10.155

-0.37 (-3.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)11-03 2025-11-03/amc
Inst Owners74.61%
Inst Owner Change-0.68%
Ins Owners1.64%
Ins Owner Change10.47%
Market Cap5.02B
Analysts53.33
Price Target8.88 (-12.56%)
Short Float %15.45%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.16%
Min EPS beat(2)-29.71%
Max EPS beat(2)-28.61%
EPS beat(4)0
Avg EPS beat(4)-49.57%
Min EPS beat(4)-90.92%
Max EPS beat(4)-28.61%
EPS beat(8)3
Avg EPS beat(8)-9.71%
EPS beat(12)4
Avg EPS beat(12)-10.03%
EPS beat(16)6
Avg EPS beat(16)-9.3%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.15%
Max Revenue beat(2)-0.88%
Revenue beat(4)0
Avg Revenue beat(4)-2.62%
Min Revenue beat(4)-5.15%
Max Revenue beat(4)-0.88%
Revenue beat(8)0
Avg Revenue beat(8)-2.4%
Revenue beat(12)2
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-0.97%
PT rev (1m)-7.67%
PT rev (3m)-21.48%
EPS NQ rev (1m)-346.69%
EPS NQ rev (3m)-409.65%
EPS NY rev (1m)-44.02%
EPS NY rev (3m)-215.73%
Revenue NQ rev (1m)-3.13%
Revenue NQ rev (3m)-8.76%
Revenue NY rev (1m)-1.52%
Revenue NY rev (3m)-3.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 1.65
EV/EBITDA N/A
EPS(TTM)-3.41
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-3
FCFYN/A
OCF(TTM)-1.74
OCFYN/A
SpS37.31
BVpS12.21
TBVpS6.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.14%
ROE -27.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 53.08%
Cap/Sales 3.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 0.61
Altman-Z N/A
F-Score2
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)76.89%
Cap/Depr(5y)95.94%
Cap/Sales(3y)3.55%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-624.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23195.24%
EPS Next Y-67.64%
EPS Next 2Y41.2%
EPS Next 3Y27.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.14%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-3.1%
Revenue Next Year1.01%
Revenue Next 2Y3.19%
Revenue Next 3Y3.45%
Revenue Next 5Y1.94%
EBIT growth 1Y-411.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year271.12%
EBIT Next 3Y82.56%
EBIT Next 5Y47.39%
FCF growth 1Y-237.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-146.02%
OCF growth 3Y-66.47%
OCF growth 5Y-28.65%